Literature DB >> 6699177

Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.

S M Lum, J T Nicoloff, C A Spencer, E M Kaptein.   

Abstract

The present study was undertaken to define the source of endogenous triiodothyronine (T3) production responsible for maintaining serum T3 levels in euthyroid subjects with depressed serum thyroxine (T4) values. After withdrawal from 4 wk of exogenous T3 administration, a 22% decline in serum T3 values (from 129 +/- 6 to 99 +/- 4 ng/dl) was observed in six euthyroid subjects, despite a twofold reduction in serum T4 concentrations (from 7.5 +/- 0.5 to 3.2 +/- 0.5 micrograms/dl). This was accompanied by a nearly twofold increase in serum T3/T4 ratio values (17 +/- 1 to 29 +/- 6) but no significant alteration in reverse T3/T4 ratio values. This phenomenon did not appear to be thyroid stimulating hormone (TSH) dependent, since base-line serum TSH values were subnormal. Nor was it dependent on changes in thyroid gland function, since a blunted T3 response to exogenous bovine TSH occurred and pharmacologic doses of iodide did not influence the phenomenon. The finding in three athyreotic subjects that serum T3/T4 ratio values increased from 14 +/- 1 on T4 therapy (mean serum T4, 9.6 +/- 0.8 micrograms/dl and T3, 132 +/- 8 ng/dl) to 40 +/- 2 after withdrawal from 2 wk of T3 administration (serum T4 1.2 +/- 0.1 micrograms/dl and T3 46 +/- 3 ng/dl) provided direct evidence that an alteration in peripheral thyroid hormone metabolism was probably responsible for these findings previously observed in euthyroid subjects. The results of this study support the possible existence in euthyroid man of a peripheral tissue autoregulatory mechanism for maintaining serum T3 values in states of T4 deficiency. Whether this process involves an alteration in the efficiency of T4 to T3 conversion or the rate of T3 clearance is presently unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699177      PMCID: PMC425050          DOI: 10.1172/JCI111245

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Changes in serum 3,3',5'-triiodothyronine (reverse T3) concentrations with altered thyroid hormone secretion and metabolism.

Authors:  M M Kaplan; M Schimmel; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

2.  The regulation of thyrotrophin secretion by exogenous thyroxine and triiodothyronine.

Authors:  P P Yeo; M Lewis; T F Davies; D R Weightman; J Marshall; J G Ratcliffe; D C Evered
Journal:  Clin Chim Acta       Date:  1979-12-17       Impact factor: 3.786

3.  Improved radioimmunoassay for human TSH.

Authors:  C A Spencer; J T Nicoloff
Journal:  Clin Chim Acta       Date:  1980-12-22       Impact factor: 3.786

Review 4.  Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications.

Authors:  P R Larsen; J E Silva; M M Kaplan
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

5.  Evidence for two tissue-specific pathways for in vivo thyroxine 5'-deiodination in the rat.

Authors:  J E Silva; J L Leonard; F R Crantz; P R Larsen
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

6.  Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.

Authors:  P R Larsen; T E Dick; B P Markovitz; M M Kaplan; T G Gard
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

Review 7.  Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications.

Authors:  M Schimmel; R D Utiger
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

8.  Effect of alterations in thyroid status on the metabolism of thyroxine and triiodothyronine by rat pituitary gland in vitro.

Authors:  M Maeda; S H Ingbar
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

9.  Extrathyroidal conversion of thyroxine to 3,3',5'-triiodothyronine (reverse-T3) and to 3,5,3'-triiodothyronine (T3) in humans.

Authors:  L Gavin; J Castle; F McMahon; P Martin; M Hammond; R R Cavalieri
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

10.  Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis.

Authors:  E M Kaptein; W J Robinson; D A Grieb; J T Nicoloff
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

View more
  27 in total

1.  Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays.

Authors:  O P Soldin; L Hilakivi-Clarke; E Weiderpass; S J Soldin
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

2.  Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry.

Authors:  Dongli Wang; Heather M Stapleton
Journal:  Anal Bioanal Chem       Date:  2010-05-01       Impact factor: 4.142

Review 3.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 4.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

5.  Detection and quantification of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by electrospray ionization tandem mass spectrometry.

Authors:  Yuntao Zhang; Abigail H Conrad; Gary W Conrad
Journal:  J Am Soc Mass Spectrom       Date:  2005-09-22       Impact factor: 3.109

6.  Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.

Authors:  E M Erfurth; P Hedner
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

7.  Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.

Authors:  N A Salomon-Montavon; A G Burger
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

8.  Differences between measurements of T4 and T3 in pregnant and nonpregnant women using isotope dilution tandem mass spectrometry and immunoassays: are there clinical implications?

Authors:  Offie P Soldin; Rochelle E Tractenberg; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2004-09       Impact factor: 3.786

9.  Isotope dilution tandem mass spectrometric method for T4/T3.

Authors:  Nadia Soukhova; Offie P Soldin; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2004-05       Impact factor: 3.786

10.  Rapid alteration in circulating free thyroxine modulates pituitary type II 5' deiodinase and basal thyrotropin secretion in the rat.

Authors:  S L Abend; S L Fang; S Alex; L E Braverman; J L Leonard
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.